LINCOLN PHARMACEUTICALS
|
The Current P/S Ratio of LINCOLN PHARMACEUTICALS is 2.63.
Share Price | ₹784.9 | Dec 26,2024 |
Market Cap | ₹1,569.8 Cr | |
Sales-TTM | ₹597.4 Cr | TTM-Consolidated Results |
Price/Sales | 2.63x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of LINCOLN PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,569.8 Cr] as on Dec 26,2024
(/) Sales [ ₹597.4 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.63x ]
Thus, for LINCOLN PHARMACEUTICALS , the investors are currently willing to pay '2.63 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of LINCOLN PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of LINCOLN PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of LINCOLN PHARMACEUTICALS
PS Ratio Performance Analysis for LINCOLN PHARMACEUTICALS
- LINCOLN PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.28x.
- LINCOLN PHARMACEUTICALS 's operated at median p/e ratio of 1.32x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LINCOLN PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 2.02x.
- LINCOLN PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 0.69x.
How does LINCOLN PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
LINCOLN PHARMACEUTICALS | 597.4 | 2.63 | 1,569.8 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 50,307.7 | 8.78 | 441,838.0 |
CIPLA LTD | 26,512.0 | 4.54 | 120,270.0 |
DR REDDYS LABORATORIES LTD | 30,084.9 | 3.76 | 113,077.0 |
ZYDUS LIFESCIENCES LTD | 21,483.5 | 4.49 | 96,553.2 |
DIVIS LABORATORIES LTD | 8,614.0 | 18.12 | 156,107.0 |
MANKIND PHARMA LTD | 11,018.0 | 10.91 | 120,212.0 |
TORRENT PHARMACEUTICALS LTD | 11,225.0 | 10.30 | 115,643.0 |
LUPIN LTD | 21,431.3 | 4.64 | 99,532.1 |
AUROBINDO PHARMA LTD | 30,295.0 | 2.41 | 72,945.8 |
ABBOTT INDIA LTD | 6,066.1 | 10.03 | 60,844.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs LINCOLN PHARMACEUTICALS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.41x |
Max industry PS | 18.12x |
Median industry PS | 4.64x |
Average industry PS | 7.33x |
You may also like the below Video Courses